Parkinson's Disease Trial, Recruiting NCT06399731 Sponsor: Amsterdam UMC Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06399731
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been formally diagnosed with Parkinson's disease by a neurologist
  • People with a mild to moderate stage of Parkinson's disease (not the most advanced stage)
  • People who show signs of mild thinking or memory difficulties, based on a recognised cognitive screening score or confirmed by neuropsychological testing (either done as part of this trial or in the past 6 months elsewhere)
  • People who take Parkinson's medication and have been on a stable, unchanged dose for at least one month before joining, and expect to stay on the same dose throughout the study

Who may not be able to join:

  • People whose test results suggest dementia rather than mild cognitive difficulties
  • People with severe depression, based on a standardised questionnaire score
  • People with a psychotic disorder (except for certain mild hallucinations where the person is aware they are not real)
  • People with signs of alcohol or drug misuse
  • People with cardiac pacemakers, implanted defibrillators, implanted medication pumps, cochlear implants, or implanted neurostimulators — due to restrictions on the brain stimulation equipment used in this trial
  • People with metal implants anywhere in the body — due to restrictions on both the brain stimulation and MRI procedures used in this trial
  • People with broken, damaged, or irritated skin at the areas where stimulation would be applied
  • People with large scars from reduced blood supply to tissue
  • People who are pregnant, or women of childbearing age who do not confirm a negative pregnancy test before joining
  • People with a personal history of epilepsy or seizures, or a family history of convulsions
  • People with brain lesions that could affect the risk of seizures
  • People with multiple sclerosis
  • People currently taking certain medications, including some antidepressants, antipsychotics, or other drugs known to lower the threshold for seizures (confirm with trial site)
  • People experiencing significant sleep deprivation during the study procedures
  • People with severe heart disease or raised pressure inside the skull
  • People with uncontrolled migraines
  • People with unexplained episodes of loss of consciousness
  • People with unstable or uncontrolled mental health conditions
  • People with vascular clips or other electrically sensitive devices in the brain
  • People with serious brain injury
  • People with certain skin conditions such as dermatitis, psoriasis, or eczema
  • People with severe or frequent headaches
  • People with serious life-threatening illness, such as severe heart failure, chronic obstructive pulmonary disease, or active cancer
  • People who have had previous brain surgery
  • People who experienced a head injury that caused unconsciousness lasting at least one hour
  • People with tattoos containing old metal-based ink, irremovable piercings, irremovable metal braces, or metal dental work — due to MRI requirements (confirm with trial site)
  • People with claustrophobia or difficulty lying still for approximately 45 minutes
  • People who have an abnormal growth or mass found on a brain MRI scan

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +31204441162

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Amsterdam UMC
Registry
ClinicalTrials.gov
Start date
31 May 2024
Est. completion
1 December 2025

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Quantative acceptability of the interventions (measured seperately)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov